Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
27.00
+0.85 (3.25%)
May 19, 2026, 4:00 PM EDT - Market closed
Pelthos Therapeutics Market Cap
Pelthos Therapeutics has a market cap or net worth of $90.6 million as of May 19, 2026. Its market cap has increased by 1,087.45% in one year.
Market Cap
90.60M
Enterprise Value
111.55M
1-Year Change
1,087.45%
Ranking
Category
Stock Price
$27.00
Market Cap Chart
Since February 16, 2024, Pelthos Therapeutics's market cap has increased from $27.68M to $90.60M, an increase of 227.26%. That is a compound annual growth rate of 69.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 90.60M | -5.32% |
| Dec 31, 2025 | 95.69M | 2,376.40% |
| Dec 31, 2024 | 3.86M | -86.04% |
| Feb 16, 2024 | 27.68M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ProMIS Neurosciences | 93.08M |
| Anixa Biosciences | 92.72M |
| ImmuCell | 90.47M |
| PolyPid | 89.31M |
| NeurAxis | 86.52M |
| Fortress Biotech | 86.04M |
| Rein Therapeutics | 85.84M |
| Champions Oncology | 83.25M |